'Partial thromboplastin time' diaporamas de présentation

Prothrombin Time (PT)

Prothrombin Time (PT). Monitor warfarin (Coumadin) therapy. Screening test for diagnosis of vitamin K deficiency. Disseminated intravascular coagulation (DIC). Diagnosis of deficiencies of coagulation proteins of the extrinsic pathway (Factor VIII) and

4.57k views • 64 slides

Coronary Artery Disease Occlusive Disorders

Coronary Artery Disease Occlusive Disorders. Angina Myocardial Infarction. Objectives. Describe occlusive disorders of the cardiovascular system. Explain the pathophysiology of common occlusive disorders. Describe nursing interventions in caring for clients with occlusive disorders.

1.31k views • 44 slides

Hemostasis/Thrombosis I

Hemostasis/Thrombosis I. Normal Hemostasis/Thrombosis; Assessment of Clotting System. HEMOSTASIS & THROMBOSIS. Platelets Coagulation Cascade Regulation of Coagulation. CIRCULATORY SYSTEM. Low volume, high pressure system Efficient for nutrient delivery to tissues

922 views • 38 slides

Major Hemorrhagic Events (Acute Phase) No significant increase in rate of major hemorrhage

Major Hemorrhagic Events (Acute Phase) No significant increase in rate of major hemorrhage. 60. Number of patients. NS. UFH. Enoxaparin. 40. NS. NS. 20. 0. ESSENCE n = 3171. TIMI 11B n = 3910. TESSMA n = 7081. UFH, unfractionated heparin; NS, not significant.

548 views • 38 slides

Blood, Lymph, & Immune Systems

486 views • 33 slides

Venothromboembolism: Orthopedic Surgery

Orthopedic Surgery and Venous Thrombosis: Relationship to Antiphospholipid Antibodies? A Pilot Study. Natalia Yazigi MD, Joseph Mazza MD, Hong Liang PhD, Mark Earll MD, William Hocking MD, James Burmester PhD, Steven Yale MD

442 views • 27 slides

1k views • 12 slides

Hemolytic Transfusion Reaction

Hemolytic Transfusion Reaction. - The incidence of immediate hemolytic transfusion reactions is estimated to be 1 per 6000-7000 units transfused. - Reactions to transfused blood products can occur as a result of the presence of constitutive antibodies ( e.g.,anti-A,anti-B )

679 views • 10 slides

Missing Slides

196 views • 10 slides

SYNERGY PCI A Subset analysis of the SYNERGY trial

SYNERGY PCI A Subset analysis of the SYNERGY trial. 4,687 high-risk ACS patients undergoing PCI after randomization to unfractionated heparin or enoxaparin. Enoxaparin 1mg/kg sc every 12 hours plus additional 0.3 mg/kg IV at time of PCI if procedure was more than 8 hrs after last sc dose.

200 views • 4 slides